Skip to main content

How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.

Publication ,  Journal Article
Bradford, WD; Kleit, AN; Nietert, PJ; Steyer, T; McIlwain, T; Ornstein, S
Published in: Health Aff (Millwood)
2006

Concern about the potential pernicious effect of direct-to-consumer (DTC) drug advertising on physicians' prescribing patterns was heightened with the 2004 withdrawal of Vioxx, a heavily advertised treatment for osteoarthritis. We examine how DTC advertising has affected physicians' prescribing behavior for osteoarthritis patients. We analyzed monthly clinical information on fifty-seven primary care practices during 2000-2002, matched to monthly brand-specific advertising data for local and network television. DTC advertising of Vioxx and Celebrex increased the number of osteoarthritis patients seen by physicians each month. DTC advertising of Vioxx increased the likelihood that patients received both Vioxx and Celebrex, but Celebrex ads only affected Vioxx use.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Health Aff (Millwood)

DOI

EISSN

2694-233X

Publication Date

2006

Volume

25

Issue

5

Start / End Page

1371 / 1377

Location

United States

Related Subject Headings

  • United States
  • Television
  • Sulfones
  • Sulfonamides
  • Pyrazoles
  • Primary Health Care
  • Practice Patterns, Physicians'
  • Physician-Patient Relations
  • Patient Satisfaction
  • Osteoarthritis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Bradford, W. D., Kleit, A. N., Nietert, P. J., Steyer, T., McIlwain, T., & Ornstein, S. (2006). How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood), 25(5), 1371–1377. https://doi.org/10.1377/hlthaff.25.5.1371
Bradford, W David, Andrew N. Kleit, Paul J. Nietert, Terrence Steyer, Thomas McIlwain, and Steven Ornstein. “How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.Health Aff (Millwood) 25, no. 5 (2006): 1371–77. https://doi.org/10.1377/hlthaff.25.5.1371.
Bradford WD, Kleit AN, Nietert PJ, Steyer T, McIlwain T, Ornstein S. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood). 2006;25(5):1371–7.
Bradford, W. David, et al. “How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior.Health Aff (Millwood), vol. 25, no. 5, 2006, pp. 1371–77. Pubmed, doi:10.1377/hlthaff.25.5.1371.
Bradford WD, Kleit AN, Nietert PJ, Steyer T, McIlwain T, Ornstein S. How direct-to-consumer television advertising for osteoarthritis drugs affects physicians' prescribing behavior. Health Aff (Millwood). 2006;25(5):1371–1377.

Published In

Health Aff (Millwood)

DOI

EISSN

2694-233X

Publication Date

2006

Volume

25

Issue

5

Start / End Page

1371 / 1377

Location

United States

Related Subject Headings

  • United States
  • Television
  • Sulfones
  • Sulfonamides
  • Pyrazoles
  • Primary Health Care
  • Practice Patterns, Physicians'
  • Physician-Patient Relations
  • Patient Satisfaction
  • Osteoarthritis